SAZ.DE : Summary for STADA ARZNEIMITT. NA O.N. - Yahoo Finance

U.S. Markets closed

STADA Arzneimittel Aktiengesellschaft (SAZ.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
64.450.00 (0.00%)
At close: 5:35PM CEST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close64.45
Bid0.00 x 5000
Ask0.00 x 28500
Day's Range64.27 - 64.52
52 Week Range36.24 - 64.95
Avg. Volume490,038
Market Cap4.01B
PE Ratio (TTM)46.70
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Financial Times13 days ago

    [$$] Bain and Cinven win ?4.1bn bidding war for German drugmaker

    Bain Capital and Cinven have won a fierce bidding war for Germany's Stada after beating a rival private equity consortium with a ?4.1bn takeover offer for the maker of generic versions of drugs such as ...

  • Financial Times13 days ago

    [$$] Stada: jam today

    A leading German politician once disparagingly referred to private equity groups and hedge funds as "locusts". But the takeover of generic drugs maker Stada is more to do with bulking it up than ...

  • Reuters13 days ago

    Bain, Cinven pay up to win backing for Stada deal

    Buyout groups Bain Capital and Cinven won an auction for German drugmaker Stada on Monday after a surprisingly large increase on a previous bid valued the company at about 5.3 billion euros ($5.6 billion). The private equity consortium is offering 65.28 euros per share and a dividend of 0.72 euro per Stada share, the company said in a statement on Monday, earning the backing of Stada management. Bain and Cinven had been vying with a rival consortium comprising Advent and Permira for control of generic drugmaker Stada.